Parapharyngeal solitary fibrous tumour: an incidental finding at ENT examination

1994 ◽  
Vol 108 (4) ◽  
pp. 344-347 ◽  
Author(s):  
A. Al-Sinawi ◽  
A. N. Johns
Keyword(s):  
Respiratory Tract ◽  
Incidental Finding ◽  
Solitary Fibrous Tumour ◽  
Outpatient Clinics ◽  
Upper Respiratory Tract ◽  
Review Of The Literature ◽  
Solitary Fibrous Tumours ◽  
Upper Respiratory ◽  
Nose And Throat

AbstractExtrapleural sites of solitary fibrous tumours have been identified. In a review of the literature 11 cases of solitary fibrous tumours of the upper respiratory tract have been reported. We report the second parapharyngeal solitary fibrous tumour which was discovered as an incidental finding emphasizing the importance of a full ear, nose and throat examination of all patients attending outpatient clinics

scholarly journals STUDIES ON EXPERIMENTAL PNEUMONIA

1920 ◽  
Vol 32 (6) ◽  
pp. 719-744 ◽  
Author(s):  
Russell L. Cecil ◽  
Francis G. Blake
Keyword(s):  
Respiratory Tract ◽  
Lower Respiratory Tract ◽  
Acute Inflammation ◽  
Early Stage ◽  
Acute Stage ◽  
Cebus Capucinus ◽  
Upper Respiratory Tract ◽  
Upper Respiratory ◽  
Lymphoid Structures ◽  
Nose And Throat

1. Virulent influenza bacilli, when injected into the nose and throat of monkeys (Cebus capucinus and Macacus syrichtus), excite an acute inflammation of the upper respiratory tract, characterized by swelling and hyperemia of the mucous membrane, infiltration of the mucosa and subrnucosa with leucocytes, desquamation of epithelial cells, and the production of a mucopurulent exudate. The accessory sinuses are often implicated in the infection. 2. Experimental Bacillus influenzæ infections of the upper respiratory tract are frequently accompanied or followed by bronchiolitis, peribronchial infiltration, and bronchopneumonia with hemorrhage and edema in the early stage, emphysema and bronchiectasis in the later stages. In general, the process closely resembles uncomplicated Bacillus influenzæ pneumonia in man. 3. The injection of virulent influenza bacilli directly into the trachea of monkeys induces in them an experimental bronchiolitis and hemorrhagic bronchopneumonia, similar in all respects to spontaneous Bacillus influenzæ pneumonia. 4. In experimental Bacillus influenzæinfections of either the upper or lower respiratory tract the influenza bacillus can usually be recovered during .the acute stage by culture, either pure or in association with other bacteria. 5. In experimental Bacillus influenzæ infections in monkeys characteristic changes occur in the thymus gland—hyperplasia of the follicles, distention of the lymphatic channels, and infiltration of the parenchyma with leucocytes. This enlargement appears to be merely part of a general hyperplasia of the lymphoid structures in the cervical and thoracic regions.

scholarly journals THE FREQUENCY OF BACILLUS INFLUENZÆ IN THE NOSE AND THROAT IN ACUTE LOBAR PNEUMONIA

1922 ◽  
Vol 35 (1) ◽  
pp. 7-15 ◽  
Author(s):  
Ernest G. Stillman
Keyword(s):  
Respiratory Tract ◽  
Upper Respiratory Tract ◽  
Lobar Pneumonia ◽  
Upper Respiratory ◽  
Nose And Throat

1. Bacillus influenza is frequently found in association with lobar pneumonia. 2. In lobar pneumonia both Bacillus influenza and pneumococcus are frequently found in the nose. 3. The influenza bacilli found in the upper respiratory tract of cases of lobar pneumonia are of various types. 4. The exact significance of these findings is at the present time not clear.

scholarly journals Conjunctival Lymphangioma: A Case Report and Brief Review of the Literature

2012 ◽  
Vol 2012 ◽  
pp. 1-4
Author(s):  
Mariana Seca ◽  
Pedro Borges ◽  
Pedro Reimão ◽  
Miguel Gomes ◽  
Angelina Meireles
Keyword(s):  
Tract Infection ◽  
Respiratory Tract ◽  
Respiratory Tract Infection ◽  
Topical Therapy ◽  
Lymphatic Vessels ◽  
Rare Condition ◽  
Upper Respiratory Tract Infection ◽  
Upper Respiratory Tract ◽  
Review Of The Literature ◽  
Upper Respiratory

Background. Lymphangioma is a rare venolymphatic lesion, characterized by dilation of lymphatic vessels. It may occur as an isolated lesion or, more often, represent the surface component of a deep orbital lymphangioma.Case. We report a case of a conjunctival lymphangioma on a 58-year-old male that had simultaneously an upper respiratory tract infection. Excision and biopsy confirmed the nature of the lesion, and there has been no relapse to date.Conclusion. Conjunctival lymphangioma is a rare condition in which the diagnose, must be kept in mind in patients with a red eye resistance to topical therapy and in association with an upper respiratory tract infection. Finally, it is also necessary to be aware of possible recurrence of the lesion.

scholarly journals SOLITARY FIBROUS TUMOUR OF THE PARANASAL SINUS PRESENTING AS AN ANTROCHOANAL POLYP

2018 ◽  
Vol 2 (2) ◽  
pp. 91-94
Author(s):  
Mansharan Kaur Chainchel Singh
Keyword(s):  
Spindle Cell ◽  
Solitary Fibrous Tumour ◽  
Urogenital System ◽  
Antrochoanal Polyp ◽  
Upper Respiratory Tract ◽  
Solitary Fibrous Tumours ◽  
Neck Area ◽  
Upper Respiratory ◽  
The Right ◽  
Mesenchymal Tumours

Solitary fibrous tumours (SFTs) are unusual mesenchymal tumours that were first described as primary spindle-cell neoplasms of the pleura. These tumours have been described in many other locations, including the urogenital system, orbit, mediastinum, and upper respiratory tract. These tumours are generally benign in nature, however some of them can be locally invasive and have the potential to be malignant. Although about 12%-15% of them occur in the head and neck area, SFT of the nasal cavity and paranasal sinuses are extremely rare. We present a case of a solitary fibrous tumour arising from the right maxillary sinus in a 50-year-old Chinese man.

ERYTHROMYCIN IN THE TREATMENT OF DIPHTHERIA AND DIPHTHERIA CARRIER STATE

PEDIATRICS ◽  
1955 ◽  
Vol 16 (3) ◽  
pp. 335-344
Author(s):  
M. W. Beach ◽  
W. B. Gamble ◽  
C. H. Zemp ◽  
Margaret Q. Jenkins
Keyword(s):  
Clinical Trial ◽  
Respiratory Tract ◽  
Carrier State ◽  
Considerable Importance ◽  
Upper Respiratory Tract ◽  
Upper Respiratory ◽  
Nose And Throat ◽  
Active Disease ◽  
Primary Form

The treatment of acute diphtheria has not been drastically changed by the use of antibiotics. Antitoxin remains the primary form of therapy. However, the eradication of virulent diphtheria bacilli from the upper respiratory tract of patients with the active disease and of carriers is of considerable importance in the control of the disease. Streptomycin is effective in vitro and in infections produced experimentally but it has not been clinically evaluated in acute diphtheria or in the carrier state. Chlortetracycline, chloramphenicol, and oxytetracyline, although active against the causative organisms, have not had sufficient clinical trial to permit evaluation in the control of diphtheria and the carrier state. Penicillin eradicates C. diphtheriae from the nasopharynx in 75 per cent of patients within a period of 3 to 4 days. In this study erythromycin eradicated the C. diptheriae from the nose and throat in all of the cases in an average of 2 days in the active cases and in an average of 3 days in the carrier state. In the treatment of diphtheria erythromycin appears on the basis of the present and of previous studies to be the most promising antibiotic developed to date. Erythromycin is advocated as an adjunct to and not as a substitute for antitoxin in the treatment of acute diphtheria.

scholarly journals Analysis of Ear, Nose and Throat Manifestations in COVID-19 Patients

2021 ◽  
Vol 25 (03) ◽  
pp. e343-e348
Author(s):  
Mohammad Waheed El-Anwar ◽  
Mohamed Eesa ◽  
Waleed Mansour ◽  
Lamia G. Zake ◽  
Ehsan Hendawy
Keyword(s):  
Respiratory Tract ◽  
Sore Throat ◽  
Nasal Congestion ◽  
Olfactory Dysfunction ◽  
Fever Hospital ◽  
Upper Respiratory Tract ◽  
University Hospitals ◽  
Clinical Criteria ◽  
Upper Respiratory ◽  
Nose And Throat

Abstract Introduction Coronavirus disease 2019 (COVID-19) has dramatically spread all over the world, crossing the borders of all countries. It is presented mainly by lower respiratory tract symptoms such as fever, cough, dyspnea, and chest tightness. However, COVID-19 causes different upper respiratory tract-related symptoms including nasal congestion, sore throat, and olfactory dysfunction. Objective To discuss different ear, nose and throat (ENT) manifestations in COVID-19-positive patients and their relation to other manifestations and to the severity of COVID-19. Methods We detected ENT manifestations in polymerase chain reaction (PCR)-confirmed positive COVID-19 patients at Zagazig Isolation Hospitals (Zagazig University hospitals, Zagazig Chest hospital, Al-Ahrar hospital, and Zagazig Fever hospital) with proportional allocation in the period from April 15 to June 15, 2020. All patients were subjected to full history taking and COVID-19 was categorized into 4 classes of severity after all patients underwent computed tomography (CT) of the chest. Afterwards, the collected data was analyzed and compared. Results Among the included 120 COVID-19 patients, the most frequent reported ENT manifestations were; sore throat (30%), nasal congestion (28.3%), nasal obstruction (26.7%), sneezing (26.6%), headache (25%), smell and taste dysfunction (25%), rhinorrhea (20%), upper respiratory tract infection (URTI) (15%), and tonsil enlargement (10%). The most common non-ENT manifestations were fever (88.3%), cough (63.3%), and dyspnea (45%). Conclusion Fever and cough are the dominant symptoms of COVID-19, but ENT manifestations for COVID-19 are common and should be a part of the suspected clinical criteria for COVID-19, particularly if the nasal examination was nonsignificant. The most common symptoms are sore throat, followed by nasal congestion and obstruction, headache, and lastly, olfactory dysfunction.

scholarly journals STUDIES ON EXPERIMENTAL PNEUMONIA

1920 ◽  
Vol 31 (4) ◽  
pp. 403-443 ◽  
Author(s):  
Francis G. Blake ◽  
Russell L. Cecil
Keyword(s):  
Tract Infection ◽  
Respiratory Tract ◽  
Respiratory Tract Infection ◽  
Upper Respiratory Tract Infection ◽  
Upper Respiratory Tract ◽  
Lobar Pneumonia ◽  
Experimental Pneumonia ◽  
Upper Respiratory ◽  
Nose And Throat ◽  
Intratracheal Injection

1. Lobar pneumonia has been consistently produced in normal monkeys by the intratracheal injection of minute amounts of pneumococcus culture. 2. The disease produced has been shown to be clinically identical with lobar pneumonia in man. 3. Lobar pneumonia has been produced in the monkey in one instance by experimental contact infection. 4. Normal monkeys inoculated in the nose and throat with large amounts of pneumococcus culture have failed to develop lobar pneumonia though carrying the organism in their mouths for at least a month. They have likewise failed to show any evidence of upper respiratory tract infection. 5. Monkeys inoculated subcutaneously or intravenously with pneumococcus culture have in no instance developed pneumonia, but have either died of pneumococcus septicemia or recovered without localization of the infection in the lungs.

Sign in / Sign up

Export Citation Format

Share Document